Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Report of Cholangiocarcinoma With Transheterozygous BRCA1 and BRCA2 Co-mutation.
Journal: Cureus
Published: May 18, 2024
Simulating Early Clinical Experiences With Surgical Procedures in the Anatomy Laboratory.
Journal: Cureus
Published: April 22, 2021
Identification of the Clinical Development Candidate MRTX849, a Covalent KRASG12C Inhibitor for the Treatment of Cancer.
Journal: Journal of medicinal chemistry
Published: April 07, 2020
Discovery of Tetrahydropyridopyrimidines as Irreversible Covalent Inhibitors of KRAS-G12C with In Vivo Activity.
Journal: ACS medicinal chemistry letters
Published: August 17, 2018
Glesatinib Exhibits Antitumor Activity in Lung Cancer Models and Patients Harboring MET Exon 14 Mutations and Overcomes Mutation-mediated Resistance to Type I MET Inhibitors in Nonclinical Models.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 24, 2017
The class I/IV HDAC inhibitor mocetinostat increases tumor antigen presentation, decreases immune suppressive cell types and augments checkpoint inhibitor therapy.
Journal: Cancer immunology, immunotherapy : CII
Published: February 27, 2017
Showing 1-7 of 7
Last Updated: 09/26/2026